Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 9Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell 5Arthritis, Rheumatoid 5Solid Tumors 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Colorectal Neoplasms 3Ovarian Neoplasms 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Uveal Melanoma 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Pancreatic Neoplasms 1Pancreatic Adenocarcinoma 1Neoplasms 1Nasopharyngeal Neoplasms 1Mesothelioma 1Melanoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Esophageal Neoplasms 1

Interventions

tocilizumab 1selicrelumab 1indusatumab 1cobimetinib 1atezolizumab 1Tiragolumab 1PEGPH20 1Oxaliplatin 1Leucovorin 1Gemcitabine 1Fluorouracil 1Bevacizumab 14-fluorobenzoyl-TN-14003 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Pancreatic Adenocarcinoma × tocilizumab × Clear all
NCT03193190 2025-11-21

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

Hoffmann-La Roche

Phase 1/2 Completed
341 enrolled 28 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡